Bafna Pharmaceuticals has informed that Kamlesh Kumar Babulal (DIN: 01218959), vide his letter dated September 09, 2023, has resigned as Non-Executive Independent Director from the Board of the Company with immediate effect on personal grounds. Kamlesh Kumar Babulal was also the Chairman of the Nomination and Remuneration Committee and Member of Audit Committee and Corporate Social Responsibility Committee of the Company. The resignation letter is enclosed (Annexure -1). Disclosures pursuant to SEBI Circular dated September 09, 2015, and Clause 7B of Para A of Part A of Schedule III to the SEBI (LODR) Regulations, 2015, are enclosed.
The above information is a part of company’s filings submitted to BSE.
